Alacramyn

· Instituto Bioclon S.A. de C.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Alacramyn, covering 2011-06-02 to 2012-05-16. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study of Alacramyn® in Pediatric Patients With Scorpion Sting Envenomation [Phase 3]